Semicarbazone-based saponin conjugate
AssigneeSapreme Technologies B.V.
InventorsGuy Hermans, Ruben Postel, Helmus Van De Langemheen, Mazdak Asadian Birjand
Life of this patent
Estimating the term…
Loading patent…
AssigneeSapreme Technologies B.V.
InventorsGuy Hermans, Ruben Postel, Helmus Van De Langemheen, Mazdak Asadian Birjand
Estimating the term…
The invention relates to a saponin derivative based on a saponin comprising a triterpene aglycone and at least one of a first saccharide chain and a second saccharide chain linked to the aglycone core structure, wherein the saponin derivative comprises an aglycone core structure comprising an aldehyde functional group which has been transformed to a semicarbazone functional group. The invention also relates to a first pharmaceutical composition comprising the saponin derivative of the invention. In addition, the invention relates to a pharmaceutical combination comprising the first pharmaceutical composition of the invention and a second pharmaceutical composition comprising for example an ADC or a GalNAc-oligonucleotide conjugate. The invention also relates to the first pharmaceutical composition or the pharmaceutical combination of the invention, for use as a medicament, or use in the treatment or prophylaxis of a cancer or an auto-immune disease, a cardiovascular disease or hypercholesterolemia, or in a method for lowering LDL-cholesterol in the circulation of a subject. The invention also relates to a saponin conjugate comprising a proteinaceous molecule, capable of binding to a cell, and optionally comprising an effector moiety such as an oligonucleotide. The invention also relates to a saponin conjugate comprising GalNAc and an oligonucleotide.
A saponin derivative based on a saponin comprising a triterpene aglycone core structure and at least one of a first saccharide chain ‘R1’ and a second saccharide chain ‘R2’ linked to the aglycone core structure, wherein the saponin derivative comprises an aglycone core structure comprising an aldehyde group, wherein the saponin on which the saponin derivative is based is a or bi-desmosidic triterpene saponin belonging to the type of a 12,13-dehydrooleanane with the aldehyde group in position C-23, and wherein the aldehyde group is transformed into a semicarbazone functional group according to formula (I)
Dependencies are inferred from the claim text.